Sleep Medicine Visit Note (Sleep Study Results Review)

Sleep Medicine Visit Note – Sleep Study Results Review

Date: [Visit date]

Encounter type: [in-person / video / phone]

Participants: [Patient and others present]

Referring provider: [Name, specialty] (Only include if applicable.)

Study reviewed: [PSG / HSAT] – [diagnostic / titration / split-night] on [Study date]

Interpreting physician: [Name, credentials]

Reason for Visit

[One to two sentences describing the visit purpose, including the patient's goals in their own words when discussed.] (Use patient-friendly language. Keep concise.)

Interval History

(Brief update since the sleep test. Use respectful phrasing such as "reports" rather than "denies". If nothing new to report, state this explicitly.)

Symptoms: [Current symptom burden including sleepiness, snoring, witnessed apneas, morning headaches, nocturia as relevant]

Safety concerns: [Drowsy driving, near-misses, occupational hazards] (Document if discussed.)

Relevant therapies/factors: [Current treatments, lifestyle factors, or changes affecting sleep] (Only include if relevant to treatment decisions.)

Sleep Study Results

Technical context: [Study type]; [Relevant limitations such as HSAT inability to measure sleep stages, limited REM/supine time, or signal quality issues]; hypopnea scoring rule: [3% desaturation with arousal / 4% desaturation only / not specified]. (If final signed report is pending, state this clearly.)

Key findings: [Plain-language summary of what the study showed, followed by numbers. Include primary breathing index with severity label, significant oxygenation findings, and positional/REM effects when treatment-relevant. Include central events or periodic limb movements only if clinically meaningful.] (Define abbreviations on first use, e.g., "apnea-hypopnea index (AHI)". Reference that full scored report is available in the chart.)

Interpretation: [Diagnosis statement]; [Whether findings explain reported symptoms]; [Caveats or next steps if indeterminate, e.g., negative HSAT with high suspicion may warrant in-lab PSG.]

Plan

Shared decision-making: [Treatment options discussed, such as PAP therapy, oral appliance, positional therapy, weight management, or surgical evaluation]; [Key points reviewed including benefits, risks, and fit with patient priorities]; [Patient's stated preferences]; [Decision reached or deferred pending further information.] (Use patient-friendly language and define abbreviations on first use.)

Chosen therapy and orders: [Selected treatment with relevant details such as PAP mode and settings, oral appliance referral, positional therapy method, or surgical referral]; [Other orders as applicable: repeat testing, labs, specialty referrals.] (Only include therapies and orders that apply to this patient.)

Risk counseling: [Drowsy driving counseling, occupational safety, medication/alcohol cautions] (Document explicitly when provided, especially for patients with daytime sleepiness or safety-sensitive occupations.)

Follow-up: [Timeframe and modality]; [What will be reviewed: PAP adherence data, symptom response, side effects]; [When to contact clinic sooner.] (Note any pending items such as final report, insurance authorization, or external records.)